Awards 2025. 07. 07
Innorna, a clinical-stage biotechnology company specialized in mRNA-LNP delivery technology, has been named to the CYZONE 2025 China Global New Forces Top 100 list. Released by Cyzone, an international innovation ecosystem service platform, the list recognizes Innorna’s exceptional innovation in mRNA-LNP technology, robust R&D capabilities, and proactive global expansion strategy.
Since its founding in 2019, Innorna has pursed its mission to address unmet medical needs globally though the development of proprietary LNP delivery technology and mRNA therapeutics. The company has established a globally oriented mRNA drug pipeline, with multiple candidates currently undergoing regulatory filings or clinical development in both China and the U.S. In addition to advancing its internal pipeline, Innorna has opened its LNP platform to external partnerships, forming diverse collaborations with leading biopharmaceutical companies through licensing agreements and joint development initiatives.
This recognition not only affirms Innorna’s R&D strengths but also reflects its growing presence in the global biotech community. It further reinforces the company’s commitment to strengthening its international footprint and bringing innovative treatments to patients worldwide. Looking ahead, Innorna will continue to invest in its core technologies, expand global partnerships, and help advance healthcare worldwide through scientific innovation.
About Innorna
Founded in 2019, Innorna is committed to developing state-of-the-art LNP delivery systems and RNA therapies to address unmet medical needs. Its proprietary Diversity-Oriented Lipid Library—with over 5,000 ionizable lipids—enables breakthroughs in mRNA vaccines/drugs, in vivo gene editing, and cell therapies. Leveraging its innovative mRNA-LNP platform, Innorna has built a robust pipeline targeting infectious diseases, rare genetic disorders, and cancer immunotherapy. Beyond its internal R&D efforts, the company collaborates with global-leading biotechnology partners to expand the reach of its transformative technology.
Recognized by investors and industry peers, Innorna has received numerous accolades including Forbes China Industry Leaders, MIT Technology Review’s 50 Smartest Companies, and Fortune China Impact Startups. Learn more at www.innorna.com.
